{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T16:59:51Z","timestamp":1705251591501},"reference-count":21,"publisher":"Japanese Pharmacological Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2011]]},"DOI":"10.1254\/jphs.10r13fm","type":"journal-article","created":{"date-parts":[[2011,2,22]],"date-time":"2011-02-22T05:20:47Z","timestamp":1298352047000},"page":"274-278","source":"Crossref","is-referenced-by-count":12,"title":["Novel Findings for the Development of Drug Therapy for Various Liver Diseases: Current State and Future Prospects for Our Liver Regeneration Therapy Using Autologous Bone Marrow Cells for Decompensated Liver Cirrhosis Patients"],"prefix":"10.1254","volume":"115","author":[{"given":"Taro","family":"Takami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Terai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Sakaida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Alison MR, Poulsom R, Jeffery R, Dhillon AP, Quaglia A, Jacob J, et al. Hepatocytes from non-hepatic adult stem cells. Nature. 2000;406:257.","DOI":"10.1038\/35018642"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.9124"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Houlihan DD, Newsome PN. Critical review of clinical trials of bone marrow stem cells in liver disease. Gastroenterology. 2008;135:438–450.","DOI":"10.1053\/j.gastro.2008.05.040"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1093\/jb\/mvg173"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1007\/s00534-005-0977-0"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20452"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Terai S, Ishikawa T, Omori K, Aoyama K, Marumoto Y, Urata Y, et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells. 2006;24:2292–2298.","DOI":"10.1634\/stemcells.2005-0542"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Gordon MY, Levicar N, Pai M, Bachellier P, Dimarakis I, Al-Allaf F, et al. Characterization and clinical application of human CD34+ stem\/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells. 2006;24:1822–1830.","DOI":"10.1634\/stemcells.2005-0629"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Levicar N, Pai M, Habib NA, Tait P, Jiao LR, Marley SB, et al. Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver disease. Cell Prolif. 2008;41:115–125.","DOI":"10.1111\/j.1365-2184.2008.00491.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 am Esch JS 2nd, Knoefel WT, Klein M, Ghodsizad A, Fuerst G, Poll LW, et al. Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells. 2005;23:463–470.","DOI":"10.1634\/stemcells.2004-0283"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2431060625"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-005-0077-0"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Omori K, Terai S, Ishikawa T, Aoyama K, Sakaida I, Nishina H, et al. Molecular signature associated with plasticity of bone marrow cell under persistent liver damage by self-organizing-map-based gene expression. FEBS Lett. 2004 3;578:10–20.","DOI":"10.1016\/j.febslet.2004.09.090"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.200500018"},{"key":"15","unstructured":"15 Terai S, Sakaida I. Current status of autologous bone marrow cell infusion therapy for liver cirrhosis patients. Hepatol Res. 2008;38(s1The 6 Japan Society of Hepatology Single Topic Conference: Liver Failure: Recent Progress and Pathogenesis to Management. 28-29 September 2007, Iwate, Japan):S72–S75."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Kim JK, Park YN, Kim JS, Park MS, Paik YH, Seok JY, et al. Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosis. Cell Transplant. 2010;19:1237–1246.","DOI":"10.3727\/096368910X506863"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, Bagheri M, Bashtar M, Ghanaati H, et al. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med. 2007;10:459–466.","DOI":"10.1182\/blood.V110.11.4864.4864"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Mohamadnejad M, Namiri M, Bagheri M, Hashemi SM, Ghanaati H, Zare Mehrjardi N, et al. Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol. 2007;13:3359–3363.","DOI":"10.3748\/wjg.v13.i24.3359"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Lyra AC, Soares MB, da Silva LF, Fortes MF, Silva AG, Mota AC, et al. Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. World J Gastroenterol. 2007;13:1067–1073.","DOI":"10.3748\/wjg.v13.i7.1067"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Lyra AC, Soares MB, da Silva LF, Braga EL, Oliveira SA, Fortes MF, et al. Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study. Eur J Gastroenterol Hepatol. 2010;22:33–42.","DOI":"10.1097\/MEG.0b013e32832eb69a"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Kharaziha P, Hellstrom PM, Noorinayer B, Farzaneh F, Aghajani K, Jafari F, et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol. 2009;2:1199–1205.","DOI":"10.1097\/MEG.0b013e32832a1f6c"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T08:10:13Z","timestamp":1637309413000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jphs\/115\/3\/115_10R13FM\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.10r13fm","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"value":"1347-8613","type":"print"},{"value":"1347-8648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}